Hurun India Rich List 2026 edition · 1 director
- #221 G Ravender Rao & family ₹16,800 Cr
Springfield Pharma Private Limited
Springfield Pharma Private Limited - real estate and construction in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Active Private Limited Company real estate and construction
Revenue · FY 2025
₹40.94 Lakh
▲ 6% YoY
Net profit · FY 2025
₹29.89 Lakh
Net margin 73%
EBITDA · FY 2025
₹39.95 Lakh
EBITDA margin 97.6%
Authorised capital
₹30.1 Cr
Registered with MCA
Paid-up capital
₹28 Cr
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
About Springfield Pharma Private Limited
Data last updated:
Springfield Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 20 August 2014 and has been in existence for over 12 years.
Its director G Ravender Rao and family are #221 on the Hurun India Rich List 2026.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74110TG2014PTC095339.
The company has an authorised share capital of ₹30.1 Cr and a paid-up capital of ₹28 Cr. It was formerly known as Springfield Nutrition Private Limited. It is led by directors Ravender Gorukanti Rao and Gorukanti Vijaya Lakshmi.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.C – 53 & 55 Road No – 16 Green Park Colony Saroornagar Karmanghat, Hyderabad, Telangana, India – 500074.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.94 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹29.89 Lakh (net margin 73%) and EBITDA of ₹39.95 Lakh (EBITDA margin 97.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Springfield Pharma Private Limited
CIN U74110TG2014PTC095339
Registration Number 095339
Incorporation Date 20 August 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
CIN History of Springfield Pharma Private Limited
Springfield Pharma has one previous CIN (Corporate Identification Number): U15400TG2014PTC095339. The current CIN is U74110TG2014PTC095339, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110TG2014PTC095339 | Current |
| U15400TG2014PTC095339 | Previous |
Recognitions & Rankings of Springfield Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.C – 53 & 55 Road No – 16 Green Park Colony Saroornagar Karmanghat, Hyderabad, Telangana, India – 500074
- IndustryReal Estate and Construction, Real Estate Builders & Developers
Comprehensive company report
Springfield Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Springfield Pharma Private Limited
The main business activity of Springfield Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Springfield Pharma Private Limited FY 2024 filings available
Springfield Pharma Private Limited reported revenue of ₹40.94 Lakh (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹40.94 Lakh ▲ 6%
Net profit · FY 2025
₹29.89 Lakh margin 73%
EBITDA · FY 2025
₹39.95 Lakh margin 97.6%
Compounded Annual Growth Rate (CAGR) of Springfield Pharma Private Limited
Revenue CAGR growth
1 year
▲ 6%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 309%
5 years · compounded
▲ 149%
Revenue rose 6% in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Springfield Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹39.95 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.89 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Springfield Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 73% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Springfield Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Springfield Pharma Private Limited
Springfield Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravender Gorukanti Rao Also directs: Austincity Living Estates LLP, Axiomaxe Property Estates LLP, Serendelta Real Estates LLP and 5 more | Director | 20 Aug 2014 | 12 Years 2 Months | Current |
| Gorukanti Vijaya Lakshmi Also directs: Summit Real Estates Pvt Ltd, Twister Constructions Private Limited, Monster Promoters Pvt Ltd and 5 more | Director | 21 Aug 2024 | 2 Years 1 Months | Current |
Peer Comparison of Springfield Pharma Private Limited
Springfield Pharma Private Limited is compared with the companies closest to it by revenue in the Real Estate industry (Builders and Developers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iceberg Developers Private Limited | ₹41 Lakh (FY 2018) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Vedantam Infosolutions Private Limited | ₹40.99 Lakh (FY 2024) | •••• | •••• | 48.0% | •••• | Lucknow, Uttar Pradesh, India |
| Sikka Infra Planet Private Limited | ₹40.98 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Delhi, India |
| Accord Infra Properties Private Limited | ₹40.97 Lakh (FY 2022) | •••• | •••• | -6.0% | •••• | Kolkata, West Bengal, India |
| Nalanda Infra Projects Private Limited | ₹40.96 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Patna, Bihar, India |
| Springfield Pharma Private Limited this company | ₹40.94 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Balsar Holdings Private Limited | ₹40.93 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Coimbatore, Tamil Nadu, India |
| Salasar Balaji Landmark Private Limited | ₹40.93 Lakh (FY 2019) | •••• | •••• | -30.0% | •••• | Jaipur, Rajasthan, India |
| Reneev Developers Private Limited | ₹40.93 Lakh (FY 2025) | •••• | •••• | •••• | Gandhinagar, Gujarat, India | |
| Simshahs Estates and Trading Company Pvt Ltd | ₹40.92 Lakh (FY 2018) | •••• | •••• | 169.0% | •••• | Mumbai, Maharashtra, India |
| Wisdom Planners and Developers Private Limited | ₹40.89 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Springfield Pharma by revenue in the Real Estate industry (Builders and Developers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Springfield Pharma Private Limited
Springfield Pharma Private Limited is audited by Sudhakar & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sudhakar & Co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Springfield Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Springfield Pharma Private Limited
Springfield Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Springfield Pharma Private Limited
Employment history and EPFO contributions of people linked to Springfield Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Springfield Pharma Private Limited
Springfield Pharma Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Gorukanti Vijaya Lakshmi ceased to be Additional Director on 25 Sep 2024.
AGM
Springfield Pharma Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Ceased
Gorukanti Vijaya Lakshmi ceased to be Additional Director.
Appointed
Gorukanti Vijaya Lakshmi was appointed as Director.
Ceased
Suguna Raman ceased to be Director.
Filing
Springfield Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Phalgun Gorukanti ceased to be Additional Director.
Appointed
Ravender Gorukanti Rao was appointed as Director.
Incorporation
20 Aug 2014
Springfield Pharma Private Limited was registered on 20 Aug 2014 with Roc Hyderabad & aged 12 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Springfield Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Springfield Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Springfield Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Springfield Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Springfield Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Springfield Pharma Private Limited
Springfield Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 20 August 2014 (12+ years old) and is registered under CIN U74110TG2014PTC095339.
Springfield Pharma reported revenue of ₹40.94 Lakh for FY 2025 (up 6% YoY).
Springfield Pharma has 2 current directors:
- Ravender Gorukanti Rao - Director
- Gorukanti Vijaya Lakshmi - Director
Springfield Pharma reported a net profit of ₹29.89 Lakh (net margin 73%) and EBITDA of ₹39.95 Lakh (EBITDA margin 97.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Springfield Pharma is U74110TG2014PTC095339. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Springfield Pharma was incorporated on 20 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Springfield Pharma by revenue are Iceberg Developers Private Limited, Vedantam Infosolutions Private Limited, Sikka Infra Planet Private Limited, Accord Infra Properties Private Limited, Nalanda Infra Projects Private Limited and 5 more, all in the Real Estate industry (Builders and Developers).
Gorukanti Vijaya Lakshmi ceased to be Additional Director on 25 Sep 2024. Gorukanti Vijaya Lakshmi was appointed as Director on 21 Aug 2024. Suguna Raman ceased to be Director on 21 Aug 2024. Springfield Pharma has 5 board changes on record in total.
The registered office of Springfield Pharma is at No.C – 53 & 55 Road No – 16 Green Park Colony Saroornagar Karmanghat, Hyderabad, Telangana, India – 500074.
Springfield Pharma has an authorised share capital of ₹30.1 Cr and a paid-up capital of ₹28 Cr.
Springfield Pharma operates in the real estate and construction industry, in the real estate builders and developers segment.